These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24210983)

  • 21. Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy.
    Corona A; Wilson AP; Grassi M; Singer M
    J Antimicrob Chemother; 2004 Oct; 54(4):809-17. PubMed ID: 15375106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stenotrophomonas maltophilia bloodstream infection: comparison between community-onset and hospital-acquired infections.
    Chang YT; Lin CY; Lu PL; Lai CC; Chen TC; Chen CY; Wu DC; Wang TP; Lin CM; Lin WR; Chen YH
    J Microbiol Immunol Infect; 2014 Feb; 47(1):28-35. PubMed ID: 23040236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
    Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
    Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study.
    Renaud B; Coma E; Labarere J; Hayon J; Roy PM; Boureaux H; Moritz F; Cibien JF; Guérin T; Carré E; Lafontaine A; Bertrand MP; Santin A; Brun-Buisson C; Fine MJ; Roupie E;
    Clin Infect Dis; 2007 Jan; 44(1):41-9. PubMed ID: 17143813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.
    Kang CI; Wi YM; Ko KS; Chung DR; Peck KR; Lee NY; Song JH
    Scand J Infect Dis; 2013 Jul; 45(7):519-25. PubMed ID: 23509913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological and clinical characteristics of occult bacteremia in an adult emergency department in Spain: influence of blood culture results on changes in initial diagnosis and empiric antibiotic treatment.
    Ramos JM; Masiá M; Elía M; Gutiérrez F; Royo G; Bonilla F; Padilla S; Martín-Hidalgo A
    Eur J Clin Microbiol Infect Dis; 2004 Dec; 23(12):881-7. PubMed ID: 15599649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia.
    Huang AM; Newton D; Kunapuli A; Gandhi TN; Washer LL; Isip J; Collins CD; Nagel JL
    Clin Infect Dis; 2013 Nov; 57(9):1237-45. PubMed ID: 23899684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approach of empirical antibiotic treatment: analyzing bacterial resistance of community-acquired bacteremia.
    Young TG; Chen YS; Yen MY
    J Microbiol Immunol Infect; 2010 Feb; 43(1):43-6. PubMed ID: 20434122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance.
    Horcajada JP; Shaw E; Padilla B; Pintado V; Calbo E; Benito N; Gamallo R; Gozalo M; Rodríguez-Baño J; ; ;
    Clin Microbiol Infect; 2013 Oct; 19(10):962-8. PubMed ID: 23279375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications, risk factors and mortality following community-onset bacteremia caused by extended-spectrum β-lactamase (ESBL) and non-ESBL producing Escherichia coli.
    Hsieh CJ; Shen YH; Hwang KP
    J Microbiol Immunol Infect; 2010 Jun; 43(3):240-8. PubMed ID: 21291853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and outcomes of polymicrobial bloodstream infections in the emergency department: A matched case-control study.
    Lin JN; Lai CH; Chen YH; Chang LL; Lu PL; Tsai SS; Lin HL; Lin HH
    Acad Emerg Med; 2010 Oct; 17(10):1072-9. PubMed ID: 21040108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
    Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
    Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Community- and non-community-acquired bacteremia: correlation between empiric antimicrobial therapy and susceptibility of micro-organisms isolated during 2007 in the Ile-de-France microbiologists network].
    Porcheret H; Barraud D; Bingen M; Rabenja T; Costa Y; Estève V; Faibis F; Demachy MC; Scanvic A; Vallée E; Péan Y
    Pathol Biol (Paris); 2010 Apr; 58(2):e7-e14. PubMed ID: 19875246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance and outcomes of Clostridium perfringens bacteremia--a 10-year experience at a tertiary care hospital.
    Yang CC; Hsu PC; Chang HJ; Cheng CW; Lee MH
    Int J Infect Dis; 2013 Nov; 17(11):e955-60. PubMed ID: 23578849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii.
    Tseng YC; Wang JT; Wu FL; Chen YC; Chie WC; Chang SC
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):181-90. PubMed ID: 17662564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult patients with occult bacteremia discharged from the emergency department: epidemiological and clinical characteristics.
    Epstein D; Raveh D; Schlesinger Y; Rudensky B; Gottehrer NP; Yinnon AM
    Clin Infect Dis; 2001 Feb; 32(4):559-65. PubMed ID: 11181118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of excess mortality in critically ill patients with nosocomial Escherichia coli bacteremia.
    Blot S; Vandewoude K; Hoste E; De Waele J; Kint K; Rosiers F; Vogelaers D; Colardyn F
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):912-5. PubMed ID: 14700406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Microbiología, sensibilidad antibiótica y factores asociados a bacteriemia en la prostatitis aguda].
    Ferré C; Llopis F; Jacob J
    Rev Esp Quimioter; 2016 Aug; 29(4):190-4. PubMed ID: 27305509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.